{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:09:53Z","timestamp":1791047393071,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,12,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Impaired apoptosis is a cancer hallmark, and some types of lymphomas and other cancers harbor mutations that directly affect key cell death regulators, such as Bcl-2 family members. However, because the majority of tumors seem to lack such mutations, we are examining the hypothesis that tumorigenesis can be sustained at least initially by the normal expression of specific endogenous pro-survival Bcl-2 family members. We previously demonstrated that the lymphomagenesis in \u0395\u03bc-myc transgenic mice, which constitutively overexpress the c-Myc oncoprotein in B-lymphoid cells and develop pre-B and B-cell lymphomas, does not require endogenous Bcl-2. In striking contrast, we report here that loss in these mice of its close relative Bcl-xL attenuated the pre-neoplastic expansion of pro-B and pre-B cells otherwise driven by c-Myc overexpression, sensitized these cells to apoptosis and ablated lymphoma formation. Remarkably, even loss of a single bcl-x allele delayed the lymphomagenesis. These findings identify Bcl-xL as a prerequisite for the emergence of c-Myc\u2013driven pre-B\/B lymphoma and suggest that BH3 mimetic drugs may provide a prophylactic strategy for c-Myc\u2013driven tumors.<\/jats:p>","DOI":"10.1182\/blood-2011-07-367672","type":"journal-article","created":{"date-parts":[[2011,10,13]],"date-time":"2011-10-13T05:35:07Z","timestamp":1318484107000},"page":"6380-6386","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":48,"title":["Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice"],"prefix":"10.1182","volume":"118","author":[{"given":"Priscilla N.","family":"Kelly","sequence":"first","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; and"},{"name":"Department of Medical Biology, Melbourne University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Grabow","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; and"},{"name":"Department of Medical Biology, Melbourne University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex R. D.","family":"Delbridge","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; and"},{"name":"Department of Medical Biology, Melbourne University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Strasser","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; and"},{"name":"Department of Medical Biology, Melbourne University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry M.","family":"Adams","sequence":"additional","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; and"},{"name":"Department of Medical Biology, Melbourne University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111807350722600_B1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer.","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"9","key":"2019111807350722600_B2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrc883","article-title":"The Bcl2 family: regulators of the cellular life-or-death switch.","volume":"2","author":"Cory","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2019111807350722600_B3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrc2297","article-title":"Diagnosing and exploiting cancer's addiction to blocks in apoptosis.","volume":"8","author":"Letai","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2019111807350722600_B4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.tcb.2008.01.007","article-title":"How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?","volume":"18","author":"Chipuk","year":"2008","journal-title":"Trends Cell Biol"},{"issue":"1","key":"2019111807350722600_B5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death.","volume":"9","author":"Youle","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5445","key":"2019111807350722600_B6","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1126\/science.286.5445.1735","article-title":"Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity.","volume":"286","author":"Bouillet","year":"1999","journal-title":"Science"},{"issue":"6","key":"2019111807350722600_B7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0092-8674(00)00187-2","article-title":"BH3-only proteins \u2013 essential initiators of apoptotic cell death.","volume":"103","author":"Huang","year":"2000","journal-title":"Cell"},{"issue":"5647","key":"2019111807350722600_B8","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.1090072","article-title":"p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa.","volume":"302","author":"Villunger","year":"2003","journal-title":"Science"},{"issue":"4","key":"2019111807350722600_B9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1535-6108(03)00244-7","article-title":"Puma is an essential mediator of p53-dependent and -independent apoptotic pathways.","volume":"4","author":"Jeffers","year":"2003","journal-title":"Cancer Cell"},{"issue":"16","key":"2019111807350722600_B10","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1073\/pnas.0401471101","article-title":"Bim is a suppressor of Myc-induced mouse B cell leukemia.","volume":"101","author":"Egle","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2019111807350722600_B11","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1097-2765(00)00136-2","article-title":"The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues.","volume":"6","author":"Lindsten","year":"2000","journal-title":"Mol Cell"},{"issue":"5813","key":"2019111807350722600_B12","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1133289","article-title":"Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak.","volume":"315","author":"Willis","year":"2007","journal-title":"Science"},{"issue":"3","key":"2019111807350722600_B13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.200905153","article-title":"The role of BH3-only protein Bim extends beyond inhibiting Bcl-2-like prosurvival proteins.","volume":"186","author":"Merino","year":"2009","journal-title":"J Cell Biol"},{"issue":"18","key":"2019111807350722600_B14","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/emboj.2011.307","article-title":"Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases.","volume":"30","author":"Strasser","year":"2011","journal-title":"EMBO J"},{"issue":"6189","key":"2019111807350722600_B15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/335440a0","article-title":"Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.","volume":"335","author":"Vaux","year":"1988","journal-title":"Nature"},{"issue":"6299","key":"2019111807350722600_B16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/348331a0","article-title":"Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.","volume":"348","author":"Strasser","year":"1990","journal-title":"Nature"},{"issue":"6306","key":"2019111807350722600_B17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/349254a0","article-title":"Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18).","volume":"349","author":"McDonnell","year":"1991","journal-title":"Nature"},{"issue":"1","key":"2019111807350722600_B18","first-page":"1","article-title":"\u0395mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells.","volume":"8","author":"Strasser","year":"1993","journal-title":"Oncogene"},{"issue":"11","key":"2019111807350722600_B19","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.4049\/jimmunol.172.11.6684","article-title":"Fatal acute lymphoblastic leukemia in mice transgenic for B cell-restricted bcl-xL and c-myc.","volume":"172","author":"Swanson","year":"2004","journal-title":"J Immunol"},{"issue":"12","key":"2019111807350722600_B20","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1182\/blood.V97.12.3902","article-title":"MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes.","volume":"97","author":"Zhou","year":"2001","journal-title":"Blood"},{"issue":"17","key":"2019111807350722600_B21","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1182\/blood-2010-04-281071","article-title":"Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem\/progenitor cells, and enhances drug resistance.","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"issue":"25","key":"2019111807350722600_B22","doi-asserted-by":"crossref","first-page":"9333","DOI":"10.1073\/pnas.0403286101","article-title":"Suppression of tumorigenesis by the p53 target PUMA.","volume":"101","author":"Hemann","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"2019111807350722600_B23","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1128\/MCB.00907-07","article-title":"Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis.","volume":"28","author":"Garrison","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"5","key":"2019111807350722600_B24","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/cdd.2008.195","article-title":"Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis.","volume":"16","author":"Michalak","year":"2009","journal-title":"Cell Death Differ"},{"issue":"3","key":"2019111807350722600_B25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ccr.2004.07.011","article-title":"Antiapoptotic BCL-2 is required for maintenance of a model leukemia.","volume":"6","author":"Letai","year":"2004","journal-title":"Cancer Cell"},{"issue":"1","key":"2019111807350722600_B26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0092-8674(92)90123-T","article-title":"Induction of apoptosis in fibroblasts by c-myc protein.","volume":"69","author":"Evan","year":"1992","journal-title":"Cell"},{"issue":"6395","key":"2019111807350722600_B27","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/359554a0","article-title":"Cooperative interaction between c-myc and bcl-2 proto-oncogenes.","volume":"359","author":"Fanidi","year":"1992","journal-title":"Nature"},{"issue":"6395","key":"2019111807350722600_B28","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/359552a0","article-title":"Apoptotic cell death induced by c-myc is inhibited by bcl-2.","volume":"359","author":"Bissonnette","year":"1992","journal-title":"Nature"},{"issue":"15","key":"2019111807350722600_B29","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1002\/j.1460-2075.1996.tb00756.x","article-title":"Progenitor tumours from \u0395mu-bcl-2-myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival.","volume":"15","author":"Strasser","year":"1996","journal-title":"EMBO J"},{"issue":"7283","key":"2019111807350722600_B30","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers.","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"issue":"11","key":"2019111807350722600_B31","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1182\/blood-2006-10-051847","article-title":"Endogenous bcl-2 is not required for the development of Emu-myc-induced B-cell lymphoma.","volume":"109","author":"Kelly","year":"2007","journal-title":"Blood"},{"issue":"6046","key":"2019111807350722600_B32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/318533a0","article-title":"The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.","volume":"318","author":"Adams","year":"1985","journal-title":"Nature"},{"issue":"5128","key":"2019111807350722600_B33","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1126\/science.8372353","article-title":"Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice.","volume":"261","author":"Nakayama","year":"1993","journal-title":"Science"},{"issue":"2","key":"2019111807350722600_B34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0092-8674(93)80065-M","article-title":"Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair.","volume":"75","author":"Veis","year":"1993","journal-title":"Cell"},{"issue":"2","key":"2019111807350722600_B35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1084\/jem.183.2.381","article-title":"Bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice.","volume":"183","author":"Grillot","year":"1996","journal-title":"J Exp Med"},{"issue":"5203","key":"2019111807350722600_B36","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1126\/science.7878471","article-title":"Massive cell death of immature hematopoietic cells and neurons in Bcl-x deficient mice.","volume":"267","author":"Motoyama","year":"1995","journal-title":"Science"},{"issue":"5","key":"2019111807350722600_B37","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(92)90029-C","article-title":"RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangements.","volume":"68","author":"Shinkai","year":"1992","journal-title":"Cell"},{"issue":"1","key":"2019111807350722600_B38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0092-8674(86)90361-2","article-title":"The c-myc oncogene perturbs B lymphocyte development in Emu-myc transgenic mice.","volume":"47","author":"Langdon","year":"1986","journal-title":"Cell"},{"issue":"2","key":"2019111807350722600_B39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.167.2.353","article-title":"The Emu-myc transgenic mouse: a model for high-incidence spontaneous lymphoma and leukemia of early B cells.","volume":"167","author":"Harris","year":"1988","journal-title":"J Exp Med"},{"issue":"4678","key":"2019111807350722600_B40","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.6093263","article-title":"Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.","volume":"226","author":"Tsujimoto","year":"1984","journal-title":"Science"},{"issue":"3","key":"2019111807350722600_B41","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/j.1460-2075.1994.tb06307.x","article-title":"Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes.","volume":"13","author":"Merino","year":"1994","journal-title":"EMBO J"},{"issue":"7252","key":"2019111807350722600_B42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature08159","article-title":"Mechanisms promoting translocations in editing and switching peripheral B cells.","volume":"460","author":"Wang","year":"2009","journal-title":"Nature"},{"issue":"7052","key":"2019111807350722600_B43","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nature03845","article-title":"Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.","volume":"436","author":"Hemann","year":"2005","journal-title":"Nature"},{"issue":"8","key":"2019111807350722600_B44","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/sj.onc.1208300","article-title":"Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM.","volume":"24","author":"Tagawa","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"2019111807350722600_B45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.gde.2009.11.001","article-title":"The ups and downs of Myc biology.","volume":"20","author":"Soucek","year":"2010","journal-title":"Curr Opin Genet Dev"},{"key":"2019111807350722600_B46","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1038\/cddis.2011.67","article-title":"Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosis.","volume":"2","author":"Pujals","year":"2011","journal-title":"Cell Death Dis"},{"issue":"6","key":"2019111807350722600_B47","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/gcc.20863","article-title":"A BACH2-BCL2L1 fusion gene resulting from a t(6;20)(q15;q11.2) chromosomal translocation in the lymphoma cell line BLUE-1.","volume":"50","author":"Turkmen","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"7042","key":"2019111807350722600_B48","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours.","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"issue":"9","key":"2019111807350722600_B49","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1158\/0008-5472.CAN-07-5836","article-title":"ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.","volume":"68","author":"Tse","year":"2008","journal-title":"Cancer Res"},{"issue":"6007","key":"2019111807350722600_B50","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1126\/science.1191793","article-title":"Mcl-1 is essential for germinal center formation and B cell memory.","volume":"330","author":"Vikstrom","year":"2010","journal-title":"Science"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/24\/6380\/1343138\/zh805011006380.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/24\/6380\/1343138\/zh805011006380.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T12:42:33Z","timestamp":1574080953000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/24\/6380\/29188\/Endogenous-BclxL-is-essential-for-Mycdriven"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,8]]},"references-count":50,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2011,12,8]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-07-367672","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,8]]}}}